Martin Windpessl retweeted
A massive group effort: 30 centers from 15 countries. A big thank you to all collaborators and the constructive review by @JASN_News! Please join @GaucklerP's presentation next Thursday during Kidney Week!
Martin Windpessl retweeted
Here is a general overview over the program! Please feel free to reach out if you have questions
Martin Windpessl retweeted
Please join us in Salzburg (Mozart city) for the 2nd Austrian Mayo Clinic Meeting. A spectacular line-up of speakers will come together to talk about diverse topics of relevance for nephrologists and hematologists (and rheumatologists). Many highlights! mayoclinic.congressinfo.eu/p…
Martin Windpessl retweeted
Please join us at what promises to be a great 2 days of Glomerular Disease Education at the RSM rsm.ac.uk/events/nephrology/… @ERAkidney @ISNkidneycare @ISGDtweets @ScottishRenal @IPNA_PedNeph @GlomCon @kidneydoc101
Costs next to nothing and welcomes virtual attendees
Martin Windpessl retweeted
It is not too late to complete the survey on management of migrants in Europe. A shared initiative of @ISNkidneycare and @ynptweets!
mailchi.mp/1febd92278df/take…
Turkey is in the lead. More responses from Central Europe, Spain, the UK, etc. are needed! @valerie_luyckx @kidneydoc101
Martin Windpessl retweeted
A wonderful overview by @philippgauckler – at Milan, Lombardy
Martin Windpessl retweeted
Kidney stones and thiazide diuretics: Revisiting old assumptions in light of the NOSTONE trial
ow.ly/MVXV30svy9Q @CKJsocial #openaccess #Urolithiasis #OpenAccess
pubmed.ncbi.nlm.nih.gov/3588… How low can you go - UOsm 29! Unusual cause of acute hyponatremia, just published in @Clin_Med with @GregorMayer4 @pm_doc and colleagues.
Martin Windpessl retweeted
as promised, thread on the 2022 CAR Contrast AKi guidelines
this was a decade after the last version pubmed.ncbi.nlm.nih.gov/2455…
1/
Yet another contrast AKI guideline
journals.sagepub.com/doi/ful…
jointly published in @CARadiologists and @CanJKHD
thread to come later - it is #OpenAccess - feel free to read and send bouquets (or brickbats) our way
Martin Windpessl retweeted
Now online - the global leader in AAV!
ANCA-Associated Vasculitis Treatment in 2022 - Prof. Jayne (Cambridge) youtu.be/axMuRzsMJII via @YouTube
Martin Windpessl retweeted
NIH UPDATE💥💥
Outpatient treatment Options (in order of preference):
Paxlovid orally twice daily for 5 days
Sotrovimab 500 mg IV single dose
Remdesivir 200 mg IV on Day 1, then 100 mg IV on D2 & 3
Molnupiravir 800 mg twice daily orally for 5d
NO fluvox
covid19treatmentguidelines.n…
Martin Windpessl retweeted
This is a quite superb response from Prof Whitty.
Martin Windpessl retweeted
And the KDIGO Guidelines for Management of Glomerular Diseases 2021 are finally out!! kdigo.org/guidelines/gd/ @goKDIGO #guidelines
(Später) Start in die Osterferien: Kubanischer Ananas-Avocado-Salat nach @katha_esskultur
Zutaten vom #Südbahnhofmarkt Linz. Schöne Aussichten für @pm_doc!
Martin Windpessl retweeted
Our new JAMA paper has important vaccine info for immunosuppressed/transplant folks: only 17% response from 1st dose. Vaccination does not mean immunity for y'all -- please be careful out there! transplantvaccine.org @CDCgov @ASTSChimera @AST_Info ja.ma/3bQmkIJ
About to start vaccination in our dialysis unit. Any recommendations re. logistic aspects, i.e. administration best at the start of the session? Any bleeding issues encountered on those on warfarin? (will aim for lowish INR prior) Lesser dose of LMW hep on the day of vacc?
Martin Windpessl retweeted
Very proud to announce that we just launched a huge, national study to understand COVID vaccine immune response and durability in (immunosuppressed) transplant patients! If you know anyone who has received an organ transplant, please share! transplantvaccine.org
Martin Windpessl retweeted
COVID-19 vaccination for adult patients with kidney disease: a position statement from the UK renal community – out now.
bit.ly/33JBsmv
@BritRenalSoc @kidneycareuk @BTStransplant @NKF_UK